OTC : CBDD

CBD of Denver, Inc.

$0.0001 USD

$0 (0.0%)

Volume
115K
Average Volume
6.84M
Market Capitalization
$1.07M
P/E Ratio
-20.25
Dividend Yield
0.00%
Price Target
Year High
$0.00
Year Low
$0.00
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.01
Company Overview

OTC

Axel Reinke

Drug Manufacturers - Specialty & Generic

Healthcare

CBDD

2

US

USD

720-434-3397

12482B107

N/A

Liquidity Metrics

-0.73

0.01

0.01

0.01

0.00

Sales & Valuation

$599.44K

1.82

-0.80

30.51

0.00

Profitability

$0

-$290.12K

-8.97%

-27.57%

3.95%

-622.80%

P/E Metrics

-20.25

0.20

0.20

Analyst Price Target & Rating

Strong Sell

1/5

0 Analysts

%

Financial Health Scores

-772.09

4/9

-$1.34M

$8516.0

$1.35M

$227.28K

Key Metrics (TTM)

$2.05M

3.46

-177.20

0.01

3.95%

3.19%

-4.94%

3.28%

-91 days

Company Executives
Name Title
Syed Hussain I. Abidi Director and Chief Executive Officer of Verde Media Biotechnology Division
Ethan Weyand Chief Financial Officer and Member of Advisory Board
William F. Veve President, Treasurer & Director
Brent LaGrange Head of Product Development & Secretary
Poll Results

No votes yet today — be the first to share your view!

About CBD of Denver, Inc. (OTC:CBDD) Stock

CBD of Denver, Inc. engages in the cultivation, production, and distribution of cannabis flower and CBD products in Switzerland, Europe, and the US. Its brands include CBD Social Network, Black Peal CBD, and Rockflowr. The company was founded in 1993 and is headquartered in Centennial, CO. ...

CBD of Denver, Inc. (CBDD) Advances Evaluation of AI-Driven Health & Wellness Acquisition Opportunity

2026-06-30 09:46:00

Denver, Colorado--(Newsfile Corp. - June 30, 2026) - CBD of Denver, Inc. (OTCID: CBDD) ("CBDD" or the "Company") today announced that it has entered the due diligence phase with respect to a prospective acquisition in the health and wellness sector. As part of the Company's ongoing acquisition plans, management has reviewed a number of businesses spanning artificial intelligence, technology, consumer products, and health and wellness.

CBD of Denver Announces Updated Corporate Website Reflecting Strategic Pivot into Artificial Intelligence

2026-06-22 10:53:00

New Website at cbdofdenver-inc.com Showcases Company's Vision for AI-Driven Growth Platforms, Marketing Automation, Workflow Efficiency, and Shareholder Value Cape Town, South Africa--(Newsfile Corp. - June 22, 2026) - CBD of Denver, Inc. (OTCID: CBDD), a publicly traded company, is pleased to announce that it has launched an updated corporate website at www.cbdofdenver-inc.com . The new website reflects the Company's exciting strategic transformation and its forward-looking direction as it actively explores merger and acquisition opportunities within the artificial intelligence (AI) sector.

CBD of Denver Announces Strategic Exploration of Merger Candidates

2026-06-11 09:00:00

Wallisellen, Switzerland--(Newsfile Corp. - June 11, 2026) - CBD of Denver, Inc. (OTC Pink: CBDD) today announced that its Board of

CBD of Denver, Inc. Identifies Strategic Opportunities to Maximize Shareholder Value

2026-05-12 09:00:00

Zurich, Switzerland--(Newsfile Corp. - May 12, 2026) - CBD of Denver Inc. (OTC Pink: CBDD) ("the Company") today announced that its management is actively pursuing potential strategic opportunities designed to position the Company for long-term growth and enhance value for its shareholders. Management is currently evaluating several prospective candidates, assets, and strategic initiatives that align with the Company's long-term vision and growth strategy.

Frequently Asked Questions

What is the current CBD of Denver, Inc. (CBDD) stock price?

CBD of Denver, Inc.(OTC:CBDD) stock price is $0.0001 in the last trading session. During the trading session, CBDD stock reached the peak price of $0.0002 while $0.0001 was the lowest point it dropped to. The percentage change in CBDD stock occurred in the recent session was 0.0% while the dollar amount for the price change in CBDD stock was $0.

CBDD's industry and sector of operation?

The OTC listed CBDD is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of CBDD?

Syed Hussain I. Abidi | Director and Chief Executive Officer of Verde Media Biotechnology Division
Ethan Weyand | Chief Financial Officer and Member of Advisory Board
William F. Veve | President, Treasurer & Director
Brent LaGrange | Head of Product Development & Secretary
|

How many employees does CBDD have?

Number of CBDD employees currently stands at 2. CBDD operates from 6436 South Quebec Street, Centennial, CO 80111, US.

Link for CBDD official website?

Official Website of CBDD is: https://www.cbdofdenver.com

How do I contact CBDD?

CBDD could be contacted at phone #720-434-3397 and can also be accessed through its website. CBDD operates from 6436 South Quebec Street, Centennial, CO 80111, US.

How many shares of CBDD are traded daily?

The average number of CBDD shares traded daily for last 3 months was 6.84M.

What is the market cap of CBDD currently?

The market value of CBDD currently stands at $1.07M with its latest stock price at $0.0001